What had been hailed a few months ago as a breakthrough in molecule-size electronics is now in doubt, and a rising star at Bell Laboratories is under suspicion of improperly manipulating data in research papers published in prestigious scientific journals. "There were funny things about the data that just shouldn't have occurred. The data was just too perfect, and we knew something was wrong." Single molecule transistors? Not yet, perhaps. Scientific intrigue at Lucent Bell Labs. As if dismal sales on the business side weren't enough to drive stock prices into the ground. | 
